Cancer Family
Malignant Neoplasm
CI-CAN-00000025CAExplore in graph →
20,116 active trials259 approved drugs3,741 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000025CAExplore in graph →
Clinical trials
90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (11,163)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05341583 | Ensartinib as Adjuvant Treatment in Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung Cancer | unknown | Phase 3 | 202 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Aug 23, 2024 | clinicaltrials |
| NCT06224387 | CTS2190 Phase I /II Clinical Study in Patients | unknown | Phase 1 / Phase 2 | 224 | CytosinLab Therapeutics Co., Ltd.INDUSTRY | 1 | Aug 23, 2024 | clinicaltrials |
| NCT06496711 | IMPLEMENT - Model Project for Quality-assured Exercise Therapy for Cancer Patients | unknown | N/A | 600 | University of CologneOTHER | 1 | Aug 23, 2024 | clinicaltrials |
| NCT06565585 | Prediction of Local Recurrence and Its Impact on Long-term Outcomes After Low-risk Glans-sparing Surgery for Penile Squamous Cell Carcinoma | unknown | — | 800 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Aug 23, 2024 | clinicaltrials |
| NCT00877214 | Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas(MAINTAIN) | unknown | Phase 3 | 1,272 | Jurgen BarthOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT02949219 | Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery | unknown | Phase 2 | 41 | Academic and Community Cancer Research UnitedOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT05887102 | Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors(PACHA) | unknown | N/A | 66 | CHU de Quebec-Universite LavalOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT06425146 | Tobacco, Alcohol and Cancerization of the Oral Mucosa (TACO)(TACO) | unknown | N/A | 30 | Centre Leon BerardOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT06463756 | AI Models to Predict Thyroid Cartilage Invasion in Laryngeal Carcinoma | unknown | — | 400 | First Affiliated Hospital of Chongqing Medical UniversityOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT06565923 | Study on the Staging and Prognosis Model of Bladder Cancer(2024-SR-386) | unknown | — | 200 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT06566391 | Ipilimumab and Nivolumab Followed by Adjuvant Nivolumab in Locally Advanced or Limited Metastatic Melanoma | unknown | Phase 2 | 35 | European Institute of OncologyOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT06566560 | The ROAD 2.0 to Sustainable Medication Use: Redispensing Unused Oral Anticancer Drugs | unknown | N/A | 2,500 | Radboud University Medical CenterOTHER | 1 | Aug 22, 2024 | clinicaltrials |
| NCT03424343 | Longitudinal Identity Study of Childhood Cancer Survivors(LInC) | unknown | — | 126 | KU LeuvenOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT03748550 | Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2)(EXACT2) | unknown | N/A | 7 | Nova Scotia Health AuthorityOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT04741906 | Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive Medication | unknown | — | 225 | Copenhagen University Hospital at HerlevOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT05024162 | Can MRI of the Prostate Combined With a Radiomics Evaluation Determine the Invasive Capacity of a Tumour(MRI-PREDICT) | unknown | N/A | 60 | Nova Scotia Health AuthorityOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT05106725 | Wearable Devices and Biomarkers Project (Healthiomics) | unknown | — | 3,500 | CureScienceOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT05229614 | Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease(ICONIC) | unknown | Phase 2 | 27 | CNAO National Center of Oncological HadrontherapyOTHER | 2 | Aug 21, 2024 | clinicaltrials |
| NCT05452668 | Laser Therapy Effect on Oral Mucositis in Childhood Acute Lymphoblastic Leukemia Patients | unknown | N/A | 51 | Children's Cancer Hospital Egypt 57357OTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT05501899 | Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia | unknown | Early Phase 1 | 20 | Children's Hospital of Orange CountyOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT05972785 | Long-term Use of CCB and Breast Cancer Risk | unknown | — | 68,500 | Curtin UniversityOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT06149169 | CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma | unknown | Phase 2 | 10 | Shanghai Ming Ju Biotechnology Co., Ltd.INDUSTRY | 1 | Aug 21, 2024 | clinicaltrials |
| NCT06564363 | The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma | unknown | — | 148 | Wuhan Ammunition Life-tech Co., LtdINDUSTRY | 1 | Aug 21, 2024 | clinicaltrials |
| NCT06564870 | Efficacy and Safety Study of DURVALUMAB Maintenance in Patients With Stage III Non-Small Cell Lung Cancer(DURVABREIZH) | unknown | — | 200 | University Hospital, BrestOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT05169853 | Programmed Death-Ligand1 Expression in Her-2 Positive and Triple Negative Breast Cancer | unknown | — | 80 | Ain Shams UniversityOTHER | 1 | Aug 20, 2024 | clinicaltrials |
| NCT05947903 | Validation of the European Oncology Quality of Life Toolkit | unknown | — | 4,000 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 32 | Aug 20, 2024 | clinicaltrials |
| NCT06215976 | The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer | unknown | Phase 4 | 78 | Cairo UniversityOTHER | 1 | Aug 20, 2024 | clinicaltrials |
| NCT06562517 | Digital Training Module for Sustainable Education of Pediatric Oncology Nurses | unknown | N/A | 104 | Koç UniversityOTHER | 1 | Aug 20, 2024 | clinicaltrials |
| NCT03612232 | Cabozantinib in Advanced Adrenocortical Carcinoma(CaboACC) | unknown | Phase 2 | 37 | Wuerzburg University HospitalOTHER | 1 | Aug 19, 2024 | clinicaltrials |
| NCT04304066 | Research for the Molecular Imaging of the PD-L1 Targeting Tracer | unknown | N/A | 50 | Peking University Cancer Hospital & InstituteOTHER | 1 | Aug 19, 2024 | clinicaltrials |
| NCT04560725 | PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer | unknown | N/A | 50 | Peking University Cancer Hospital & InstituteOTHER | 1 | Aug 19, 2024 | clinicaltrials |
| NCT04596670 | 68Ga-ICAM-1pep PET/CT in Cancer Patients | unknown | Early Phase 1 | 20 | Peking University Cancer Hospital & InstituteOTHER | 1 | Aug 19, 2024 | clinicaltrials |
| NCT06558903 | Searching for Predictive Biomarkers of Efficacy in Small Cell Lung Cancer Patients Treated With Chemotherapy-immunotherapy Combination Using Imaging Mass Cytometry (HYPE)(HYPE) | unknown | — | 20 | University Hospital, BrestOTHER | 1 | Aug 19, 2024 | clinicaltrials |
| NCT06561022 | Precision Treatment of HR+ HER2- Advanced Breast Cancer Based on SNF Molecular Subtyping(abemaSNF1/3) | unknown | Phase 2 | 260 | Fudan UniversityOTHER | 1 | Aug 19, 2024 | clinicaltrials |
| NCT03256201 | Exercise and Nutrition to Improve Pancreatic Cancer Outcomes | unknown | N/A | 95 | University of OklahomaOTHER | 1 | Aug 16, 2024 | clinicaltrials |
| NCT04271527 | Non-inferiority Randomized Controlled Trial of Cognitive Targeted Biopsy Versus Software Targeted Biopsy | unknown | N/A | 626 | Shanghai East HospitalOTHER | 1 | Aug 16, 2024 | clinicaltrials |
| NCT05182866 | ASP-1929 Photoimmunotherapy (PIT) Study in Patients With Recurrent Head/Neck Cancer | unknown | Phase 2 | 9 | Rakuten Medical, Inc.INDUSTRY | 1 | Aug 16, 2024 | clinicaltrials |
| NCT05351502 | A Study to Assess the Safety and Efficacy of Nitric Oxide Injection Into Unresectable Solid Primary or Metastatic Tumors | unknown | Phase 1 | 38 | Beyond Air Inc.INDUSTRY | 1 | Aug 16, 2024 | clinicaltrials |
| NCT05867303 | A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors | unknown | Phase 1 | 48 | RemeGen Co., Ltd.INDUSTRY | 2 | Aug 16, 2024 | clinicaltrials |
| NCT01890590 | A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma | unknown | N/A | 46 | Beth Israel Deaconess Medical CenterOTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT05222087 | PRIME_LUNG: Primary Radiotherapy In MEtastatic Lung Cancer - A Pilot Study(PRIME_LUNG) | unknown | Phase 1 | 40 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT05385250 | Bone-sparing Chemoradiotherapy for Anal Cancer - DACG-II(DACG-II) | unknown | N/A | 100 | Karen-Lise Garm SpindlerOTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT05597683 | Quadratus Lumborum Block After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy | unknown | N/A | 50 | Gangnam Severance HospitalOTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT05719779 | Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.(Ronco-Onco) | unknown | N/A | 35 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT06475170 | Preliminary Efficacy Analysis of 'λ+α' Double-Tract Reconstruction After Laparoscopic Proximal Gastrectomy | unknown | N/A | 60 | Northern Jiangsu People's HospitalOTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT06540027 | The Effect of Minimally Invasive Surgery on Systemic Inflammatory Response in Rectal Cancer | unknown | — | 80 | Başakşehir Çam & Sakura City HospitalOTHER_GOV | 1 | Aug 15, 2024 | clinicaltrials |
| NCT06556004 | Phase 1 Study Using TRIMELVax for Stage IIIC / IV Melanoma Patients(Trimelvax001) | unknown | Phase 1 | 20 | University of ChileOTHER | 1 | Aug 15, 2024 | clinicaltrials |
| NCT05570279 | PLAN-A Data- Bio- and Plan- Bank Collection for SCCA in Denmark(PLAN-A) | unknown | — | 314 | Aarhus University HospitalOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT05605379 | CML Pediatric ITK Response According to Molecular Identification at Diagnosis(CML Piramid) | unknown | — | 88 | University Hospital, BordeauxOTHER | 1 | Aug 14, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Aug 23, 2024source: clinicaltrials